The Ischemic Stroke Market growth continues to surge as secondary prevention strategies evolve from generic antithrombotic approaches toward personalized, risk-stratified management protocols. With recurrent stroke representing a major source of morbidity and healthcare expenditure, the demand for sophisticated risk assessment tools and targeted prevention interventions is experiencing...